Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Sep;1(5):556–562. doi: 10.1128/cdli.1.5.556-562.1994

Granulocyte colony-stimulating factor does not enhance phagocytosis or microbicidal activity of human mature polymorphonuclear neutrophils in vitro.

N Shimono 1, K Okada 1, D Takeda 1, K Eguchi 1, H Misumi 1, Y Sawae 1, Y Niho 1
PMCID: PMC368338  PMID: 8556501

Abstract

The direct effects of human granulocyte colony-stimulating factor (hG-CSF) on mature polymorphonuclear neutrophils (PMNs) in vitro were studied with regard to chemotaxis, superoxide production, and phagocytosis and microbicidal activity against the following viable microorganisms: Staphylococcus aureus, serum-resistant Pseudomonas aeruginosa, and Candida albicans. Recombinant hG-CSF (rhG-CSF) acted as a chemoattractant for human PMNs in a dose-dependent manner. The chemotactic response of PMNs to N-formyl-methionyl-leucyl-phenylalanine (FMLP) was not enhanced by rhG-CSF at any of the concentrations used. rhG-CSF did not induce the generation of superoxide by itself. However, rhG-CSF was able to prime human PMNs and to enhance O2- release stimulated by FMLP in a dose-dependent manner. rhg-CSF did not enhance phagocytosis or killing of the three species of microorganisms by normal PMNs. With PMNs obtained from patients who had hematological disorders or solid tumors, no enhancement of the microbicidal activity was observed in most cases. Microbial killing mediated by PMNs depended on the ratio of PMNs to target organisms. We concluded from these facts that the most important effect of rhG-CSF was to increase the number of the peripheral PMNs and not to enhance the functions of mature PMNs.

Full text

PDF
556

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begley C. G., Lopez A. F., Nicola N. A., Warren D. J., Vadas M. A., Sanderson C. J., Metcalf D. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood. 1986 Jul;68(1):162–166. [PubMed] [Google Scholar]
  2. Bonilla M. A., Gillio A. P., Ruggeiro M., Kernan N. A., Brochstein J. A., Abboud M., Fumagalli L., Vincent M., Gabrilove J. L., Welte K. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989 Jun 15;320(24):1574–1580. doi: 10.1056/NEJM198906153202402. [DOI] [PubMed] [Google Scholar]
  3. Bronchud M. H., Potter M. R., Morgenstern G., Blasco M. J., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer. 1988 Jul;58(1):64–69. doi: 10.1038/bjc.1988.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen A. M., Hines D. K., Korach E. S., Ratzkin B. J. In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor. Infect Immun. 1988 Nov;56(11):2861–2865. doi: 10.1128/iai.56.11.2861-2865.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fujisawa M., Kobayashi Y., Okabe T., Takaku F., Komatsu Y., Itoh S. Recombinant human granulocyte colony-stimulating factor induces granulocytosis in vivo. Jpn J Cancer Res. 1986 Sep;77(9):866–869. [PubMed] [Google Scholar]
  6. Glaspy J. A., Baldwin G. C., Robertson P. A., Souza L., Vincent M., Ambersley J., Golde D. W. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med. 1988 Nov 15;109(10):789–795. doi: 10.7326/0003-4819-109-10-789. [DOI] [PubMed] [Google Scholar]
  7. Ichinose Y., Hara N., Ohta M., Aso H., Chikama H., Kawasaki M., Kubota I., Shimizu T., Yagawa K. Recombinant granulocyte colony-stimulating factor and lipopolysaccharide maintain the phenotype of and superoxide anion generation by neutrophils. Infect Immun. 1990 Jun;58(6):1647–1652. doi: 10.1128/iai.58.6.1647-1652.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kawakami M., Tsutsumi H., Kumakawa T., Abe H., Hirai M., Kurosawa S., Mori M., Fukushima M. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990 Nov 15;76(10):1962–1964. [PubMed] [Google Scholar]
  9. Kitagawa S., Yuo A., Souza L. M., Saito M., Miura Y., Takaku F. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun. 1987 May 14;144(3):1143–1146. doi: 10.1016/0006-291x(87)91430-6. [DOI] [PubMed] [Google Scholar]
  10. Kondo S., Okamura S., Ohhara N., Niho Y. Direct action of human granulocyte colony-stimulating factor on mature human neutrophils: flow-cytometric analysis. Res Commun Chem Pathol Pharmacol. 1990 Feb;67(2):249–257. [PubMed] [Google Scholar]
  11. Matsumoto M., Matsubara S., Matsuno T., Tamura M., Hattori K., Nomura H., Ono M., Yokota T. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun. 1987 Nov;55(11):2715–2720. doi: 10.1128/iai.55.11.2715-2720.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood. 1986 Feb;67(2):257–267. [PubMed] [Google Scholar]
  13. Morstyn G., Lieschke G. J., Sheridan W., Layton J., Cebon J., Fox R. M. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Semin Hematol. 1989 Apr;26(2 Suppl 2):9–13. [PubMed] [Google Scholar]
  14. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. 1986 Jan 30-Feb 5Nature. 319(6052):415–418. doi: 10.1038/319415a0. [DOI] [PubMed] [Google Scholar]
  15. Nathan C. F. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood. 1989 Jan;73(1):301–306. [PubMed] [Google Scholar]
  16. Negrin R. S., Haeuber D. H., Nagler A., Olds L. C., Donlon T., Souza L. M., Greenberg P. L. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial. Ann Intern Med. 1989 Jun 15;110(12):976–984. doi: 10.7326/0003-4819-110-12-976. [DOI] [PubMed] [Google Scholar]
  17. Nishimura Y., Mayumi H., Tomita Y., Eto M., Maeda T., Nomoto K. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system. J Immunol. 1991 Apr 15;146(8):2639–2647. [PubMed] [Google Scholar]
  18. Ohsaka A., Kitagawa S., Sakamoto S., Miura Y., Takanashi N., Takaku F., Saito M. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood. 1989 Dec;74(8):2743–2748. [PubMed] [Google Scholar]
  19. Okada Y., Kawagishi M., Kusaka M. Effect of recombinant human granulocyte colony-stimulating factor on human neutrophil adherence in vitro. Experientia. 1990 Oct 15;46(10):1050–1053. doi: 10.1007/BF01940670. [DOI] [PubMed] [Google Scholar]
  20. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Roilides E., Walsh T. J., Pizzo P. A., Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis. 1991 Mar;163(3):579–583. doi: 10.1093/infdis/163.3.579. [DOI] [PubMed] [Google Scholar]
  22. Shinomiya N., Tsuru S., Katsura Y., Kayashima S., Nomoto K. Enhanced resistance against Listeria monocytogenes achieved by pretreatment with granulocyte colony-stimulating factor. Infect Immun. 1991 Dec;59(12):4740–4743. doi: 10.1128/iai.59.12.4740-4743.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wang J. M., Chen Z. G., Colella S., Bonilla M. A., Welte K., Bordignon C., Mantovani A. Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood. 1988 Nov;72(5):1456–1460. [PubMed] [Google Scholar]
  24. Yasuda H., Ajiki Y., Shimozato T., Kasahara M., Kawada H., Iwata M., Shimizu K. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun. 1990 Aug;58(8):2502–2509. doi: 10.1128/iai.58.8.2502-2509.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yuo A., Kitagawa S., Ohsaka A., Ohta M., Miyazono K., Okabe T., Urabe A., Saito M., Takaku F. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood. 1989 Nov 1;74(6):2144–2149. [PubMed] [Google Scholar]
  26. Yuo A., Kitagawa S., Okabe T., Urabe A., Komatsu Y., Itoh S., Takaku F. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood. 1987 Aug;70(2):404–411. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES